- Home
- MIRM vs GLBE Comparison
MIRM vs GLBE Comparison
Compare MIRM & GLBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIRM | GLBE |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 6.2B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MIRM | GLBE |
|---|---|---|
| Price | $93.42 | $38.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $119.85 | $47.08 |
| AVG Volume (30 Days) | 456.7K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,138,000.00 | N/A |
| Revenue This Year | $26.22 | $31.78 |
| Revenue Next Year | $22.04 | $24.45 |
| P/E Ratio | ★ N/A | $89.26 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $63.23 | $26.85 |
| 52 Week High | $130.00 | $43.99 |
Technical Indicators
Market Signals| Indicator | MIRM | GLBE |
|---|---|---|
| Relative Strength Index (RSI) | 38.75 | 49.49 |
| Support Level | $88.08 | $37.78 |
| Resistance Level | $98.03 | $38.32 |
| Average True Range (ATR) | 3.82 | 1.38 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 1.32 | 59.10 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About GLBE Global-E Online Ltd.
Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from, and to, anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.